The office of the Congressionally Directed Medical Research Programs (CDMRP) manages Congressional Special Interest Medical Research Programs (CSI) encompassing various diseases, conditions, military health, and other specified areas. Since fiscal year 1992, the CDMRP has managed over $19.7 billion in Congressional appropriations for peer-reviewed research aimed at advancing paradigm shifting research, solutions that will lead to cures or improvements in patient care, or breakthrough technologies and resources for clinical benefit. Through fiscal year 2023, approximately 21,479 awards have been made to advance health care solutions via extramural grants, contracts, and cooperative agreements.

FY25 Funded Research Programs

• Alzheimer's
• Amyotrophic Lateral Sclerosis
• Breast Cancer
• Duchenne Muscular Dystrophy
• Melanoma
• Military Burn
• Ovarian Cancer
• Peer Reviewed Cancer
• Peer Reviewed Medical
• Prostate Cancer
• Rare Cancers
• Toxic Exposures

Previously Funded Research Programs

• Alcohol and Substance Use Disorders
• Arthritis
• Autism
• Bone Marrow Failure
• Chronic Pain Management
• Combat Readiness-Medical
• Epilepsy
• Glioblastoma
• Gulf War Illness
• Hearing Restoration
• Joint Warfighter Medical
• Kidney Cancer
• Lung Cancer
• Lupus
• Multiple Sclerosis
• Neurofibromatosis
• Neurotoxin Exposure Treatment Parkinson's
• Orthotics and Prosthetics Outcomes
• Pancreatic Cancer
• Parkinson's
• Peer Reviewed Orthopaedic
• Reconstructive Transplant Research
• Scleroderma
• Spinal Cord Injury
• Tick-Borne Disease
• Traumatic Brain Injury and Psychological Health
• Tuberous Sclerosis Complex
• Vision

Other Defense Health Program Support

• Defense Medical Research and Development